• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经肝脏脂肪变性指数定义的胎次对非酒精性脂肪性肝病风险的影响:一项全国性队列研究。

The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study.

作者信息

Hong So-Hyeon, Hwang Soon Young, Yu Ji Hee, Kim Nam Hoon, Yoo Hye Jin, Seo Ji A, Kim Sin Gon, Kim Nan Hee, Baik Sei Hyun, Choi Kyung Mook

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.

Department of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.

出版信息

Sci Rep. 2025 Jul 24;15(1):26972. doi: 10.1038/s41598-025-11976-x.

DOI:10.1038/s41598-025-11976-x
PMID:40707536
Abstract

Despite the impact of pregnancy and parity on the prevalence of metabolic diseases, there are limited epidemiologic data regarding the association between parity and nonalcoholic fatty liver disease (NAFLD). We examined the association between parity, parity number, and NAFLD risk in pre- and postmenopausal women using data representing the entire Korean population. This cohort included 28,003 women (13,145 premenopausal and 14,858 postmenopausal) from the Korean National Health and Nutrition Examination Survey. NAFLD was defined by the hepatic steatosis index. Multivariable logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). The prevalence of NAFLD was 21.0% (15.3% in premenopausal women and 26.1% in postmenopausal women). In premenopausal women, parity increased the odds of NAFLD in the unadjusted model (OR 1.72, 95% CI 1.49-2.00), but after adjustment for potential confounders, including obesity, it exhibited a protective effect (OR 0.61, 95% CI 0.46-0.80). This finding was consistent when participants were divided into low parity (1-2 births) and high parity (3 or more births) groups (OR 0.59, 95% CI 0.45-0.79, and OR 0.64, 95% CI 0.47-0.87, respectively). In postmenopausal women, there was no significant statistical association between parity and NAFLD. These findings remained consistent across several sensitivity analyses excluding potential risk factors and in subgroup analyses. After adjusting for various confounding parameters, including obesity, parity was associated with a lower risk of NAFLD in premenopausal women. This suggests a protective effect of parity on NAFLD in premenopausal women, provided that appropriate body weight and other metabolic risk factors are maintained after delivery.

摘要

尽管妊娠和生育次数对代谢性疾病的患病率有影响,但关于生育次数与非酒精性脂肪性肝病(NAFLD)之间关联的流行病学数据有限。我们利用代表整个韩国人群的数据,研究了绝经前和绝经后女性的生育次数、生育胎次与NAFLD风险之间的关联。该队列包括来自韩国国家健康与营养检查调查的28,003名女性(13,145名绝经前女性和14,858名绝经后女性)。NAFLD由肝脏脂肪变性指数定义。采用多变量逻辑回归分析计算比值比(OR)和95%置信区间(CI)。NAFLD的患病率为21.0%(绝经前女性为15.3%,绝经后女性为26.1%)。在绝经前女性中,生育次数在未调整模型中增加了NAFLD的患病几率(OR 1.72,95% CI 1.49 - 2.00),但在调整包括肥胖在内的潜在混杂因素后,生育次数呈现出保护作用(OR 0.61,95% CI 0.46 - 0.80)。当参与者被分为低生育次数(1 - 2次分娩)和高生育次数(3次或更多次分娩)组时,这一发现是一致的(分别为OR 0.59,95% CI 0.45 - 0.79和OR 0.64,95% CI 0.47 - 0.87)。在绝经后女性中,生育次数与NAFLD之间没有显著的统计学关联。这些发现在排除潜在风险因素的多项敏感性分析和亚组分析中保持一致。在调整包括肥胖在内的各种混杂参数后,生育次数与绝经前女性较低的NAFLD风险相关。这表明生育次数对绝经前女性的NAFLD具有保护作用,前提是产后保持适当体重和其他代谢风险因素。

相似文献

1
The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study.经肝脏脂肪变性指数定义的胎次对非酒精性脂肪性肝病风险的影响:一项全国性队列研究。
Sci Rep. 2025 Jul 24;15(1):26972. doi: 10.1038/s41598-025-11976-x.
2
Nonalcoholic fatty liver disease and female sexual dysfunction in Egyptian premenopausal women: is there a link between metabolic syndrome and sexual function?埃及绝经前女性的非酒精性脂肪性肝病与女性性功能障碍:代谢综合征与性功能之间是否存在关联?
J Sex Med. 2024 Sep 3;21(9):770-776. doi: 10.1093/jsxmed/qdae080.
3
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
4
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
5
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.非酒精性脂肪性肝病(NAFLD)的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 30;3(3):CD011640. doi: 10.1002/14651858.CD011640.pub2.
6
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的生活方式干预:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013156. doi: 10.1002/14651858.CD013156.pub2.
7
Antioxidants for male subfertility.用于男性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2014(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15.
8
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
9
Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based study.饮食亲脂性指数与代谢功能障碍相关脂肪性肝病(MASLD)的患病几率:一项基于人群的研究。
Dig Liver Dis. 2025 Jul;57(7):1455-1464. doi: 10.1016/j.dld.2025.04.001. Epub 2025 May 13.
10
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.

本文引用的文献

1
G protein-coupled estrogen receptor 1 ameliorates nonalcoholic steatohepatitis through targeting AMPK-dependent signaling.G 蛋白偶联雌激素受体 1 通过靶向 AMPK 依赖信号改善非酒精性脂肪性肝炎。
J Biol Chem. 2024 Mar;300(3):105661. doi: 10.1016/j.jbc.2024.105661. Epub 2024 Jan 20.
2
How does gestational weight gain influence short- and long-term postpartum weight retention? An updated systematic review and meta-analysis.妊娠体重增加如何影响产后短期和长期体重滞留?一项更新的系统评价和荟萃分析。
Obes Rev. 2024 Apr;25(4):e13679. doi: 10.1111/obr.13679. Epub 2024 Jan 14.
3
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
4
Estrogen as a key regulator of energy homeostasis and metabolic health.雌激素作为能量平衡和代谢健康的关键调节剂。
Biomed Pharmacother. 2022 Dec;156:113808. doi: 10.1016/j.biopha.2022.113808. Epub 2022 Oct 15.
5
Parity and Metabolic Syndrome Risk: A Systematic Review and Meta-Analysis of 15 Observational Studies With 62,095 Women.产次与代谢综合征风险:对15项涉及62,095名女性的观察性研究的系统评价和荟萃分析
Front Med (Lausanne). 2022 Jul 12;9:926944. doi: 10.3389/fmed.2022.926944. eCollection 2022.
6
Menopause: a cardiometabolic transition.绝经:一种心脏代谢转变。
Lancet Diabetes Endocrinol. 2022 Jun;10(6):442-456. doi: 10.1016/S2213-8587(22)00076-6. Epub 2022 May 4.
7
Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.非酒精性脂肪性肝病贯穿女性一生:性激素的作用。
J Endocrinol Invest. 2022 Sep;45(9):1609-1623. doi: 10.1007/s40618-022-01766-x. Epub 2022 Mar 18.
8
Global burden of NAFLD and chronic liver disease among adolescents and young adults.青少年和青年中非酒精性脂肪性肝病及慢性肝病的全球负担。
Hepatology. 2022 May;75(5):1204-1217. doi: 10.1002/hep.32228. Epub 2021 Dec 21.
9
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.母乳喂养与经产妇女非酒精性脂肪性肝病的相关性:一项全国性队列研究。
Hepatology. 2021 Dec;74(6):2988-2997. doi: 10.1002/hep.32034. Epub 2021 Jul 26.
10
NAFLD in Lean Asians.瘦亚洲人的非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):240-243. doi: 10.1002/cld.930. eCollection 2020 Dec.